ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,066.00
      -0.07%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.00%
      Bitcoin
      66,977.22
      -0.15%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. NovaBay Pharmaceuticals Inc New (NBY)

      7. NovaBay Pharmaceuticals Inc New (NBY) News

      NBY

      NovaBay Pharmaceuticals (NBY)

      NovaBay Pharmaceuticals Inc New
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:NBY
      DateTimeSourceHeadlineSymbolCompany
      3:00PMiHub NewswireFeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements
      05/13/20248:30AMBusiness WireNovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye SymptomsAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/09/20244:05PMBusiness WireNovaBay Pharmaceuticals Reports First Quarter 2024 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/07/20248:00AMBusiness WireNovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through AmazonAMEX:NBYNovaBay Pharmaceuticals Inc New
      05/03/20246:50AMBusiness WireNovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
      04/22/20246:57AMBusiness WireNovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova SalesAMEX:NBYNovaBay Pharmaceuticals Inc New
      04/19/20246:00PMBusiness WireNovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder EquityAMEX:NBYNovaBay Pharmaceuticals Inc New
      04/17/20246:59AMBusiness WireNovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing ExpensesAMEX:NBYNovaBay Pharmaceuticals Inc New
      03/26/20244:05PMBusiness WireNovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
      03/25/20246:38PMBusiness WireNovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
      03/14/20248:00AMBusiness WireNovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023AMEX:NBYNovaBay Pharmaceuticals Inc New
      02/14/20242:52PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
      02/06/202411:52AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
      01/30/20249:00AMBusiness WireNovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based SalesAMEX:NBYNovaBay Pharmaceuticals Inc New
      01/10/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
      01/09/20249:15AMBusiness WireNovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor NetworkAMEX:NBYNovaBay Pharmaceuticals Inc New
      01/04/202411:50AMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesAMEX:NBYNovaBay Pharmaceuticals Inc New
      12/21/20237:58AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
      12/11/20234:32PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
      12/06/20236:50AMBusiness WireNovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic MembranesAMEX:NBYNovaBay Pharmaceuticals Inc New
      11/09/20234:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NBYNovaBay Pharmaceuticals Inc New
      11/09/20234:05PMBusiness WireNovaBay Pharmaceuticals Reports Third Quarter 2023 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
      11/02/20236:50AMBusiness WireNovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023AMEX:NBYNovaBay Pharmaceuticals Inc New
      10/11/20238:00AMBusiness WireNovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova ProgramsAMEX:NBYNovaBay Pharmaceuticals Inc New
      10/02/20236:50AMBusiness WireNovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth ConferenceAMEX:NBYNovaBay Pharmaceuticals Inc New
      09/21/20239:35AMGlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceAMEX:NBYNovaBay Pharmaceuticals Inc New
      09/14/20238:00AMBusiness WireNovaBay Pharmaceuticals Announces Commercial Launch of Avenova® AllograftAMEX:NBYNovaBay Pharmaceuticals Inc New
      09/11/20238:00AMBusiness WireNovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® AllograftAMEX:NBYNovaBay Pharmaceuticals Inc New
      08/10/20234:47PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NBYNovaBay Pharmaceuticals Inc New
      08/10/20234:05PMBusiness WireNovaBay Pharmaceuticals Reports Second Quarter 2023 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
       Showing the most relevant articles for your search:AMEX:NBY